Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

Top Structural Heart News of 2022

News Daily News

Top Structural Heart News of 2022

January 06, 2023

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

News Daily News

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

December 06, 2022

COVID-19: TCTMD’s Dispatch for October Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 3

October 18, 2021

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

June 23, 2021

COVID-19: TCTMD’s Daily Dispatch for May Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 1

May 02, 2021

New Advanced Training Outlined for Future Vascular Medicine Specialists

News Daily News

New Advanced Training Outlined for Future Vascular Medicine Specialists

Michael O'Riordan

January 21, 2021

COVID-19: TCTMD’s Daily Dispatch for December

News Daily News

COVID-19: TCTMD’s Daily Dispatch for December

December 01, 2020

More Circulating Omega-3s May Boost Prognosis After STEMI

News Daily News

More Circulating Omega-3s May Boost Prognosis After STEMI

October 26, 2020

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

News Daily News

Stricter Regulations Needed to Maximize Cuts in Sodium Intake, UK Study Suggests

Marcus A. Banks

July 22, 2019

Abciximab in ‘Short Supply’ Worldwide

News Daily News

Abciximab in ‘Short Supply’ Worldwide

April 13, 2018

Rivaroxaban’s “Overwhelming” Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

February 08, 2017

News Daily News

Según un Gran Meta Análisis Parecida Mortalidad al cabo de 30 Días y 1 Año con TAVR Versus Cirugía

Michael O'Riordan

June 07, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Daily News

大规模 Meta 分析显示，TAVR 与手术 30 天和 1 年死亡率相当

Michael O'Riordan

June 07, 2016

News Daily News

研究表明，年满 90 岁患者不应排除 TAVR 方案

July 27, 2015

News Daily News

Un Estudio Sugiere que Tener 90 Años o Más No Debería de Excluir la TAVR

July 27, 2015

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.